Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
00:48
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

54th ERA-EDTA Congress

 

3rd-6th June 2017 Madrid
FAQs
   
Discussion forum - 54th ERA-EDTA Congress
    Topic - Renal transplantation - Treatment & immunosuppre

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER
  
 Thread / Poster  Author  Replies  Last reply
COMPARISON BETWEEN THREE DOSAGES OF THYMOGLOBULIN FOR INDUCTION IN KIDNEY TRANSPLANTATION  Nooshin Dalili 1      5/28/2017 2:50:00 PM  
AVESTA STUDY- AN IRANIAN VERIFICATION OF EVEROLIMUS SUCCESS IN TRANSPLANTATION ASPECTS  Nooshin Dalili 1      5/28/2017 1:45:00 PM  
HEPATITIS C VIRUS IN KIDNEY TRANSPLANT RECIPIENTS: DIRECT ACTING ANTIVIRALS TREATMENT. ERADICATION OF A PROBLEM  CARMEN GONZALEZ CORVILLO 1      5/28/2017 10:39:00 AM  
HIGH RISK HUMAN PAPILLOMAVIRUS INFECTION IN FEMALE KIDNEY TRANSPLANT RECIPIENTS  Ieva Ziedina 1      5/25/2017 10:13:00 PM  
MEDICATION ADHERENCE AND SELF MANAGEMENT IN KIDNEY TRANSPLANT RECIPIENTS  Barbora Vankova 1      5/25/2017 9:58:00 PM  
EXTENDING VALGANCICLOVIR PROPHYLAXIS IN KIDNEY TRANSPLANT RECIPIENTS IS ASSOCIATED WITH LOWER INCIDENCE OF CYTOMEGALOVIRUS INFECTION  Botjan Bizjak 1      5/25/2017 5:10:00 PM  
DE NOVO DONOR-SPECIFIC HLA ANTIBODIES AFTER STEROID WITHDRAWAL IN KIDNEY TRANSPLANT RECIPIENTS: A PROSPECTIVE, RANDOMIZED, CONTROLLED, PARALLEL GROUP STUDY. PRELIMINARY RESULTS  Juana Alonso-Titos 1      5/25/2017 12:05:00 PM  
EFFECTS OF IL-1 RECEPTOR ANTAGONIST IN KIDNEY TRANSPLANT RECIPIENTS  Erol Demir 1      5/25/2017 8:36:00 AM  
HIGH- VERSUS LOW-TITER ANTI-ABO ANTIBODY IN ABO INCOMPATIBLE LIVING DONOR KIDNEY TRANSPLANTATION  Sung Son 1      5/25/2017 3:03:00 AM  
HEMOLYTIC ANEMIA AFTER KIDNEY TRANSPLANT WITH POLYCLONAL ANTIBODIES  Alice Lana 1      5/24/2017 11:45:00 PM  
INTRAPATIENT VARIABILITY IN PATIENTS SWITCHED FROM TWICE DAILY TO ONCE DAILY TACROLIMUS  Hiba Azar 1      5/24/2017 11:39:00 PM  
DIRECT-ACTING ANTIVIRALS IN KIDNEY TRANSPLANT RECIPIENTS WITH HEPATITIS C VIRUS INFECTION: A SPANISH MULTICENTER STUDY  CARMEN GONZALEZ CORVILLO 1      5/24/2017 10:47:00 PM  
The Role of TWEAK in Calcineurin Inhibitor Nephrotoxicity (CNT)  Daniel Sidler 1      5/24/2017 5:29:00 PM  
TRANSIENT SUPPRESSION OF PRO-INFLAMMATORY T-CELL SUBSETS AFTER LPS CHALLENGE IN A HUMAN, EXPERIMENTAL ENDOTOXINAEMIA MODEL  Alexandra Brinkhoff 1      5/24/2017 5:27:00 PM  
IMPACT OF THE MAINTENANCE IMMUNOSUPPRESSIVE THERAPY ON THE FECAL MICROBIOME OF RENAL TRANSPLANT RECIPIENTS: COMPARISON BETWEEN AN EVEROLIMUS- VERSUS A STANDARD TACROLIMUS-BASED REGIMEN  Gianluigi Zaza 1      5/24/2017 4:29:00 PM  
SNPs PROFILING OF RENAL ALLOGRAFT RECIPIENTS WITH ACUTE REJECTION  Elisa Scalzotto 1      5/24/2017 4:20:00 PM  
COMBINATION THERAPY OF RITUXIMAB AND INTRAVENOUS IMMUNOGLOBULIN AS AN EFFECTIVE TREATMENT FOR CHRONIC ANTIBODY-MEDIATED REJECTION IN KIDNEY TRANSPLANT RECIPIENTS  Woo Yeong Park 1      5/24/2017 2:15:00 PM  
IS THE VALACYCLOVIR PROPHYLAXIS EFFECTIVE FOR PREVENTION OF CYTOMEGALOVIRUS INFECTION IN KIDNEY TRANSPLANT RECIPIENTS?  Woo Yeong Park 1      5/24/2017 2:12:00 PM  
INFLUENCE OF SOFOSBUVIR-BASED THERAPY OF CHRONIC HEPATITIS C ON BLOOD CONCENTRATION OF CALCINEURIN INHIBITORS IN KIDNEY TRANSPLANT PATIENTS  Joanna Musialik 1      5/24/2017 2:11:00 PM  
EFFECTIVENESS AND SAFETY OF SOFOSBUVIR-BASED THERAPY OF CHRONIC HEPATITIS C PATIENTS AFTER KIDNEY TRANSPLANTATION  Joanna Musialik 1      5/24/2017 2:06:00 PM  
POST-RENAL TRANSPLANT LEUCOPENIA AND ITS IMPACT ON GRAFT AND PATIENT OUTCOME  Mohamed Adel 1      5/24/2017 1:25:00 PM  
LOW DOSE VALGANCICLOVIR PROPHYLAXIS AMONG RENAL TRANSPLANTS: COST BENEFIT ANALYSIS  Mohamed Adel 1      5/24/2017 1:23:00 PM  
INFLUENCE OF CYTOCHROME P450 3A5 (CYP3A5) GENTEIC POLYMORPHISM ON SHORT-TERM OUTCOMES IN KIDNEY TRANSPLANT RECIPIENTS TREATED WITH TACROLIMUS  TANIA LINARES GRÁVALOS 1      5/24/2017 12:53:00 PM  
TREATMENT OF HEPATITIS C VIRUS IN RENAL TRANSPLANT PATIENTS. RESULTS FROM A SINGLE CENTRE WITH THE USE OF DIRECT ANTIVIRAL AGENTS  Jordi Soler Majoral 1      5/24/2017 2:17:00 AM  
METABOLIC AND RENAL OUTCOMES OF KIDNEY TRANSPLANTATION IN OVERWEIGHT OR OBESE PATIENTS: THE IMPACT OF EARLY STEROID WITHDRAWAL  Thomas JOUVE 1      5/24/2017 1:02:00 AM  
RENAL TRANSPLANTATION IN AVERAGE SENSITIZED RECIPIENTS  Alexey Zulkarnaev 1      5/23/2017 11:10:00 PM  
TRANSPLANTATION AND DIALYSIS CENTER BACTERIAL PROFILE ANALYSIS: NINETEEN-YEAR REPORT (1998-2016)  Alexey Zulkarnaev 1      5/23/2017 11:08:00 PM  
RENAL TRANSPLANT ISCHEMIA/REPERFUSION INJURY CORRECTION WITH CYTOKINES ADSORPTION: EARLY AND LONG-TERM RESULTS  Alexey Zulkarnaev 1      5/23/2017 10:49:00 PM  
EXTRACORPOREAL PHOTOPHERESIS IN RENAL TRANSPLANTATION  Alexey Zulkarnaev 1      5/23/2017 10:44:00 PM  
PLASMA EXCHANGE AND DOUBLE FILTRATION PLASMAPHERESIS IN THE TREATMENT OF RENAL GRAFT ANTIBODY MEDIATED REJECTION  Alexey Zulkarnaev 1      5/23/2017 10:40:00 PM  
Immunosuppressive drugs (6-MP, MPA, Rapa) act as modulators of metabolic reprogramming in Jurkat T cell line  Ana A Fernandez Ramos 1      5/23/2017 4:39:00 PM  
EFFICIENT WORK UP KIDNEY TRANSPLANTATION/KIDNEYDONATION, IN A NON ACADEMIC HOSPITAL  Dačnne Scheuter 1      5/23/2017 10:49:00 AM  
VISUAL EVOKED POTENTIALS IN STABLE KIDNEY TRANSPLANT RECIPIENTS TREATED EITHER WITH CYCLOSPORINE A- OR TACROLIMUS-BASED REGIMENS  Aureliusz Kolonko 1      5/23/2017 8:12:00 AM  
RESULTS OF STEM CELL AND RENAL TRANSPLANTATION IN PATIENTS WITH END STAGE RENAL DISEASE AFTER PLASMA CELL DYSCRASIA  MARIA MOLINA GÓMEZ 1      5/18/2017 7:34:00 PM  
DIAGNOSTIC BRONCHOSCOPY IN KIDNEY TRANSPLANT RECIPIENTS WITH ACUTE RESPIRATORY FAILURE  Dmytro Khadzhynov 1      5/16/2017 4:28:00 PM  
FETUIN-A LEVELS IN KIDNEY TRANSPLANT RECIPIENTS WITH CARDIAC VALVULAR CALCIFICATION  Alparslan Ersoy 1      5/16/2017 2:41:00 PM  
CHANGES OF A BODY SHAPE INDEX IN KIDNEY RANSPLANT RECIPIENTS WHO RECEIVED CALCINEURIN INHIBITOR BASED IMMUNOSUPPRESSIVE REGIMEN  Alparslan Ersoy 1      5/16/2017 2:39:00 PM  
ADVANTAGES OF CONVERSION FROM TWICE DAILY TO ONCE DAILY TACROLIMUS INTAKE IN KIDNEY TRANSPLANTATION  Bagdat Sultanova 1      5/15/2017 8:28:00 AM  
HEPATITIS E AND IMMUNOSUPPRESSION  Samina Hussain 1      5/13/2017 12:35:00 AM  
       




Most viewed poster for this congress
Poster: 9
Visits: 267
Title: Report on dialysis and kidney transplantation in Serbia 2011-2014. Compare to others
Authors: Simic Ogrizovic Sanja ,
Centre: Serbian society of nephrology

Poster most viewed in this topic
Poster: 814
Visits: 27
Title: ADVANTAGES OF CONVERSION FROM TWICE DAILY TO ONCE DAILY TACROLIMUS INTAKE IN KIDNEY TRANSPLANTATION
Authors: Bagdat Sultanova , Inkar Mansurova1, Bagdat Sultanova1, Meruert Mukanova2, Shynar Sarsenova2, 1Kazakh Medical University of Continuous Education, Nephrology, Almaty, KAZAKHSTAN, 2Municipal Clinical Hospital 7, Nephrology, Almaty, KAZAKHSTAN.
Centre: Kazakh Medical University of Continuous Education


 




PosterSessionOnline
Logo Draft
 
Logo Cert